FULGENT GENETICS, INC. Investment Tax Credit
FULGENT GENETICS, INC. (FLGT) reported Investment Tax Credit of $106.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:InvestmentTaxCredit · last filed 2026-02-27
- FULGENT GENETICS, INC. investment tax credit for the quarter ending 2025-12-31 was $72.50M.
- FULGENT GENETICS, INC. investment tax credit for the quarter ending 2025-06-30 was $33.80M.
- FULGENT GENETICS, INC. investment tax credit for the quarter ending 2024-09-30 was $27.10M.
- FULGENT GENETICS, INC. investment tax credit for fiscal 2025 was $106.30M, a 292.25% increase from fiscal 2024.
- FULGENT GENETICS, INC. investment tax credit for fiscal 2024 was $27.10M.
| Period end | Investment Tax Credit 3 month | Investment Tax Credit 9 month | Investment Tax Credit 12 month |
|---|---|---|---|
| 2025-12-31 | $72.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $106.30M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $33.80M 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $33.80M 10-Q · filed 2025-08-01 | ||
| 2024-12-31 | $27.10M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $27.10M 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |